Year: 1998
Type: article
Abstract: The MICs of 13 antibiotics (doxycycline, thiamphenicol, rifampin, amoxicillin, gentamicin, co-trimoxazole, ciprofloxacin, pefloxacin, ofloxacin, erythromycin, josamycin, clarithromycin, and pristinamycin) were determined for 27 available rickettsial species or strains. We used two in vitro cell culture methods described previously: the plaque assay and the microplaque colorimetric assay. Our results confirm the susceptibilities of rickettsiae to doxycycline, thiamphenicol, and fluoroquinolones. Beta-lactams, aminoglycosides, and cotrimoxazole were not active. Typhus group rickettsiae were susceptible to all macrolides tested, whereas the spotted fever group rickettsiae, R. bellii, and R. canada were more resistant, with josamycin, a safe alternative for the treatment of Mediterranean spotted fever, being the most effective compound. Strain Bar 29, R. massiliae, R. montana, R. aeschlimannii, and R. rhipicephali, which are members of the same phylogenetic subgroup, were more resistant to rifampin than the other rickettsiae tested. Heterogeneity in susceptibility to rifampin, which we report for the first time, may explain in vivo discrepancies in the effectiveness of this antibiotic for the treatment of rickettsial diseases. We hypothesize that rifampin resistance and erythromycin susceptibility may reflect a divergence during the evolution of rickettsiae.
Authors: J. M. Rolain, M. Maurin, G. Vestris, D. Raoult
Institution: Centre National de la Recherche Scientifique
Language: English
Subfield: Parasitology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: Rickettsia, antimicrobial susceptibility, minimum inhibitory concentration, doxycycline, thiamphenicol, fluoroquinolones, macrolides, josamycin, rifampicin resistance, erythromycin, spotted fever group rickettsiae, typhus group rickettsiae, Rickettsia rhipicephali, Rickettsia aeschlimannii, Rickettsia massiliae, Rickettsia bellii, Mediterranean spotted fever
Open Access status: bronze
OpenAlex ID: W2138144134
